GUBBA PHARMA IN E NEWS

Read More

Indian excipient industry to approach DCGI to curb irrational usage of excipients in domestic market

November 27, 2019 Gubba Pharma In E News

The Indian excipient industry is planning to approach the Drugs Controller General of India (DCGI) to frame India specific guidelines to curb irrational usage of...

Continue Reading

Read More

Indian device for cancer fight gets USFDA’s ‘breakthrough’ tag

November 27, 2019 Gubba Pharma In E News

The US Food and Drug Administration (FDA)’s Centre for Devices and Radiological Health has designated a medical invention by a Bengaluru-based scientist as a “breakthrough...

Continue Reading

Read More

Union commerce secretary urge healthcare industry to set up online portal to facilitate medical tourism in India

November 20, 2019 Gubba Pharma In E News

Union Commerce Secretary Dr Anup Wadhawan has urged the healthcare industry to set up an online portal to facilitate international patients coming to India for...

Continue Reading

Read More

Illegal cancer drugs from Bangladesh flood local market

November 20, 2019 Gubba Pharma In E News

It’s not just import of raw materials (active pharmaceutical ingredients, or APIs) from China that is giving sleepless nights to domestic pharma companies. Now, “illegal”...

Continue Reading

Read More

Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases

November 20, 2019 Gubba Pharma In E News

Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, today announced an option, research and license agreement worth up to...

Continue Reading

Read More

Enzene opens its first continuous biologics manufacturing facility

November 14, 2019 Gubba Pharma In E News

Enzene Biosciences, a subsidiary of Alkem Laboratories, has formally opened its first fully connected continuous Biologics manufacturing facility in Pune. This first-of-its-kind facility was built...

Continue Reading

Read More

Govt gives go-ahead for 4 medical device parks

November 14, 2019 Gubba Pharma In E News

The government has given approval for setting up four medical device parks with a view to support Make in India initiative and provide world-class products...

Continue Reading

Read More

Regulator waives off clinical trials, clears Sanofi TB drug

November 6, 2019 Gubba Pharma In E News

India’s drug regulator has approved (India)’s new anti-tuberculosis drug rifapentine , waiving local clinical trials in a move to bolster efforts to prevent latent infections...

Continue Reading

Read More

J&J unveils next-gen monofocal intraocular lens in India

November 6, 2019 Gubba Pharma In E News

In an endeavour recognizing the need to provide solutions to post-operative cataract patients to enhance vision, Johnson & Johnson Vision, a global leader in eye...

Continue Reading